Reducing Disparities in Medication Adherence of Patients With Systemic Lupus Erythematosus (SLE)

Duke University1 site in 1 country135 target enrollmentOctober 2, 2019

ConditionsSystemic Lupus Erythematosus

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Systemic Lupus Erythematosus
Sponsor: Duke University
Enrollment: 135
Locations: 1
Primary Endpoint: Acceptability as Measured by Provider Survey
Status: Completed
Last Updated: 10 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus

Registry

clinicaltrials.gov

Start Date

October 2, 2019

End Date

June 7, 2020

Last Updated

10 months ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Duke University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Acceptability as Measured by Provider Survey

Time Frame: 12 weeks

Acceptability as measured by provider survey, score range 1-5, with a higher score indicating that the intervention was more acceptable.

Feasibility as Measured by Number of Participants With EMR (Electronic Medical Record) Documentation of Adherence

Time Frame: 12 weeks

Feasibility as measured by documentation of adherence assessment made by provider.

Secondary Outcomes

Percentage of Adherent Participants as Determined by Medication Possession Ratio (MPR)(Baseline, 12 weeks)
Medication Adherence as Determined by Self Report(12 weeks)